» Authors » Gantt P Galloway

Gantt P Galloway

Explore the profile of Gantt P Galloway including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 1300
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallgren K, Galloway G, Witkiewitz K, Linde P, Nix B, Mendelson J
Am J Drug Alcohol Abuse . 2023 Mar; 49(2):249-259. PMID: 36881813
Alcohol use disorder (AUD) treatments, including medications, are increasingly offered via telehealth. This study characterizes 90-day treatment retention and changes in objectively measured blood alcohol concentration (BAC) in a large...
2.
Baggott M, Garrison K, Coyle J, Galloway G, Barnes A, Huestis M, et al.
J Psychoactive Drugs . 2019 Apr; 51(2):108-117. PMID: 30967099
Entactogens such as 3,4-Methylenedioxymethamphetamine (MDMA, "molly", "ecstasy") appear to have unusual, potentially therapeutic, emotional effects. Understanding their mechanisms can benefit from clinical experiments with related drugs. Yet the first known...
3.
Baggott M, Garrison K, Coyle J, Galloway G, Barnes A, Huestis M, et al.
Adv Pharmacol Sci . 2016 Jul; 2016:2175896. PMID: 27403159
Hyponatremia is a serious complication of 3,4-methylenedioxymethamphetamine (MDMA) use. We investigated potential mechanisms in two double-blind, placebo-controlled studies. In Study 1, healthy drug-experienced volunteers received MDMA or placebo alone and...
4.
Pal R, Mendelson J, Clavier O, Baggott M, Coyle J, Galloway G
J Psychoactive Drugs . 2016 Jun; 48(4):288-94. PMID: 27260123
Introduction: In methamphetamine (MA) users, drug-induced neurocognitive deficits may help to determine treatment, monitor adherence, and predict relapse. To measure these relationships, we developed an iPhone app (Neurophone) to compare...
5.
Baggott M, Coyle J, Siegrist J, Garrison K, Galloway G, Mendelson J
J Psychopharmacol . 2016 Feb; 30(4):378-87. PMID: 26880224
The drug 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy", "molly") is a widely used illicit drug and experimental adjunct to psychotherapy. MDMA has unusual, poorly understood socioemotional effects, including feelings of interpersonal closeness and...
6.
Korcha R, Polcin D, Evans K, Bond J, Galloway G
Counselor (Deerfield Beach) . 2015 Aug; 16(3):62-69. PMID: 26236173
Motivational interviewing (MI) for the treatment of alcohol and drug problems is typically conducted over 1 to 3 sessions. This paper reports on an evaluation of an intensive 9-session version...
7.
Keoleian V, Polcin D, Galloway G
J Psychoactive Drugs . 2015 May; 47(2):158-76. PMID: 25950596
Individuals seeking treatment for addiction often experience barriers due to cost, lack of local treatment resources, or either school or work schedule conflicts. Text-messaging-based addiction treatment is inexpensive and has...
8.
Anderson A, Li S, Markova D, Holmes T, Chiang N, Kahn R, et al.
Drug Alcohol Depend . 2015 Mar; 150:170-4. PMID: 25818061
Aim: Bupropion was tested for efficacy to achieve methamphetamine (MA) abstinence in dependent, non-daily users. Methods: A randomized, double-blind, placebo-controlled trial, with 12-week treatment and 4-week follow-up, was conducted with...
9.
Pal R, Mendelson J, Flower K, Garrison K, Yount G, Coyle J, et al.
J Addict Med . 2015 Jan; 9(2):130-5. PMID: 25622123
Objectives: Methamphetamine (MA) addiction has no known effective pharmacotherapy. Small trials showed beneficial effects for oral naltrexone in amphetamine users. Trials in alcohol-dependent subjects showed better response in persons with...
10.
Polcin D, Bond J, Korcha R, Nayak M, Galloway G, Evans K
J Addict Dis . 2014 Aug; 33(3):253-65. PMID: 25115166
An intensive, 9-session motivational interviewing (IMI) intervention was assessed using a randomized clinical trial of 217 methamphetamine (MA) dependent individuals. Intensive motivational interviewing (IMI) was compared with a single standard...